Management
DiNAQOR was founded and is led by several leading pharmaceutical and biotechnology executives and academics with deep cardiology and gene therapy expertise.
Johannes Holzmeister, MD
Chairman & Chief Executive Officer
Mark Dehdashtian
Executive Vice President, Medical Devices
Thomas Eschenhagen, MD
Chief Scientific Advisor
Chris Rusconi, PhD
Chief Development Officer
Hans Rudolf Trüeb
General Counsel & Corporate Secretary
Reto Wittwer
Chief Financial Officer
Steven Zelenkofske, DO, MS
Chief Strategy Officer
Josef El Andari, PhD
Senior Scientist AAV Vector Development